Rapid Relief Menthol Pain Patch

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor pain.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 12 years and older, the following dosage and administration guidelines apply:

The patch should be applied to the affected area after carefully removing the backing. The sticky side of the patch must be placed directly on the skin. Each patch may be worn for a maximum of 8 hours. It is permissible to repeat the application as necessary, but no more than three patches should be used in a 24-hour period. After a single use, the patch must be discarded appropriately.

Once the pouch is opened, it should be resealed to maintain the integrity of the remaining patches.

For children under 12 years of age, it is essential to consult a physician prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

Application is prohibited on wounds, cuts, damaged, or infected skin due to the risk of exacerbating the condition. It should not be applied to the eyes, mouth, genitals, or any mucous membranes to prevent irritation or adverse reactions. Additionally, tight bandaging or the use of heating pads in conjunction with this product is contraindicated, as it may lead to increased absorption and potential toxicity. Concurrent use with other topical analgesics is also contraindicated to avoid additive effects and potential overdose.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to avoid ingestion of the product. In the event of accidental swallowing, immediate medical assistance should be sought by contacting a Poison Control Center at 800-222-1222.

Healthcare providers should monitor patients for any adverse reactions. Patients must be instructed to discontinue use and consult their physician if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, recurrence of symptoms after initial improvement, or any signs of skin injury, including pain, swelling, or blistering at the application site.

Additionally, it is recommended that pregnant or breastfeeding individuals consult a healthcare professional prior to using this product to ensure safety for both mother and child.

Side Effects

Patients should be aware that the product is intended for external use only. It is important to stop use and consult a healthcare professional if any of the following occur: the condition worsens, redness is present, irritation develops, symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Additionally, patients should seek medical advice if they experience signs of skin injury, such as pain, swelling, or blistering at the site of application.

For pregnant or breastfeeding individuals, it is recommended to consult a health professional before using the product to ensure safety and appropriateness.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Rapid Relief Menthol Pain Patch (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may use this medication. For children under 12 years of age, it is recommended to consult a physician prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and breastfeeding infants are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with a healthcare provider to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include alterations in consciousness, respiratory distress, cardiovascular instability, and other systemic effects.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and clinical status, and initiate supportive care as necessary. It is crucial to obtain a detailed history of the substance involved, including the amount and route of administration, to guide further management.

Management of overdose may involve the use of specific antidotes, if available, and supportive measures such as airway management, intravenous fluids, and monitoring in a controlled setting. Consultation with a poison control center or toxicology expert is advised for guidance on the appropriate management strategies tailored to the specific situation.

In summary, while no specific overdosage information is provided, healthcare professionals should be prepared to act swiftly and effectively in the event of an overdose, utilizing their clinical judgment and available resources to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 800-222-1222 if the product is swallowed. Patients should be instructed to avoid applying the product on wounds, cuts, damaged, or infected skin, as well as on the eyes, mouth, genitals, or any other mucous membranes.

It is important for healthcare providers to inform patients to monitor their condition closely. They should be advised to report to their healthcare provider if their condition worsens, if redness or irritation develops, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Patients should also be made aware of signs of skin injury, such as pain, swelling, or blistering at the site of application, and to seek medical advice if these occur.

For patients who are pregnant or breastfeeding, healthcare providers should recommend consulting a health professional before use. Patients must be reminded to use the product only as directed and to be aware that rare cases of serious burns have been reported with similar products.

Additionally, healthcare providers should instruct patients not to bandage the area tightly or use a heating pad in conjunction with the product. It is crucial to avoid contact with the eyes and mucous membranes, and patients should be cautioned against applying the product to wounds or damaged skin. Finally, patients should be advised not to use this product simultaneously with other topical analgesics.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15-30℃ (59-86℉) to maintain its efficacy. Additionally, the product should be kept out of reach of children to ensure safety. Proper handling and storage conditions are crucial for preserving the integrity of the product.

Additional Clinical Information

The route of administration for the product is topical, with patients advised to wear one patch for up to 8 hours. The patch may be reapplied as necessary, but should not exceed three applications in a single day.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before use. Additionally, it is important to keep the product out of reach of children; if ingested, medical assistance should be sought immediately or contact a Poison Control Center at 800-222-1222. No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Rapid Relief Menthol Pain Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)